TTY Biopharm Company Limited (TPEX: 4105)
Health Care · Pharmaceuticals · TW
NT$78.40
+3.02% today · +2.3% 1Y
TTY Biopharm Company Limited (TPEX: 4105) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $612.20M and employs 561 people.
Over the last twelve months the share price has gained 2.3%, trading between 71.60 and 87.00.
Tweenvest scores TTY Biopharm Company Limited across four factors: quality 88/100, value 75/100, growth 62/100, dividend 79/100. Its strongest factor is quality.
4105 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $612.20M
- Revenue (TTM)
- $209.15M
- P/E
- 11.26
- EPS
- 6.96
- Dividend yield
- 5.74%
- Beta (5Y)
- 0.11
- 52-week high
- NT$87.00
- 52-week low
- NT$71.60
- Avg volume (3M)
- —
- Shares outstanding
- 248.65M
- Employees
- 561
- Next earnings
- —
About TTY Biopharm Company Limited
TTY Biopharm Company Limited, along with its associated entities, specializes in the creation and distribution of pharmaceutical and chemical products across Taiwan and global markets. Its operations are structured into several key divisions: Oncology, Intensive Care, Healthcare, Export & CDMO, and an "Other" Business Unit. For anti-cancer and supportive therapies, the company markets a range of oncology medications under prominent brand names such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. Addressing infectious diseases and influenza, TTY Biopharm supplies anti-infection drugs including Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. Furthermore, the firm offers various healthcare-related pharmaceuticals designed for the digestive system, osteoporosis, and metabolic conditions, marketed under brands like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. Beyond pharmaceuticals, the company is also involved in distributing functional foods, conducting international trade (import/export), and engaging in investment ventures. Established in 1960, TTY Biopharm maintains its principal office in Taipei, Taiwan.
- ISIN
- TW0004105002
- Founded
- 1960
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.